Clinical Trial Detail

NCT ID NCT02143050
Title Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors James Graham Brown Cancer Center
Indications

melanoma

Therapies

Dabrafenib + Metformin + Trametinib

Age Groups: adult

Additional content available in CKB BOOST